Skip to main content

Table 2 Changes in pulmonary function

From: A typical presentation of moxifloxacin-induced DRESS syndrome with pulmonary involvement: a case report and review of the literature

 

D18

D29

D54

FVC/predicted value (%)

119

120

137

FEV1/predicted value (%)

111

113

127

FEV1/FVC (%)

75

76

75

DLCO/predicted value (%)

54

69

90

FEV1 increased (ml)a

 > 200

 < 200

 < 200

FEV1 increased (%)a

19

1

2

  1. aThe drug used in the bronchial relaxation test is salbutamol sulfate 300 ug
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us